ConductScience.org, home

Paper8096416

Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.

Smyth ET and 5 others. BMJ, 1993. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. Papers, record 8096416. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8096416

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
PubMed
Journal
BMJ
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.88
iCite
Revised in PubMed
2019-05-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smyth ETE T
2Pavord IDI D
3Wong CSC S
4Wisniewski AFA F
5Williams JJ
6Tattersfield AEA E

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AgonistsMajor topic
AlbuterolMajor topic
AsthmaMajor topic
Adolescent
Adult
Double-Blind Method
Drug Administration Schedule
Drug Interactions
Female
Forced Expiratory Volume
Heart Rate
Humans
Male
Middle Aged
Potassium
Salmeterol Xinafoate
Stimulation, Chemical
Therapeutic Equivalency

Source PubMed

Download CSV of topics

Comments and corrections4

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in8098239Dose equivalence of drugs for asthma.https://conductscience.org/library/papers/8098239PubMed
Comment in8490514Dose equivalence of drugs for asthma.https://conductscience.org/library/papers/8490514PubMed
Comment in8490515Dose equivalence of drugs for asthma.https://conductscience.org/library/papers/8490515PubMed
Comment in9240063Several studies have shown salmeterol to be more potent than salbutamol for systemic effects.https://conductscience.org/library/papers/9240063PubMed

Download CSV of comments and corrections

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16474387Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma.Thorax1984https://conductscience.org/library/papers/6474387PubMed
27362736Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7362736PubMed
32565417Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.Lancet1989https://conductscience.org/library/papers/2565417PubMed
42330548Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.Thorax1990https://conductscience.org/library/papers/2330548PubMed
52349198The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.Postgrad Med J1990https://conductscience.org/library/papers/2349198PubMed
61975162Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis.Am Rev Respir Dis1990https://conductscience.org/library/papers/1975162PubMed
71978872Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.Lancet1990https://conductscience.org/library/papers/1978872PubMed
82014490Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.Thorax1991https://conductscience.org/library/papers/2014490PubMed
91679981A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.Am Rev Respir Dis1991https://conductscience.org/library/papers/1679981PubMed
101346340The use of beta-agonists and the risk of death and near death from asthma.N Engl J Med1992https://conductscience.org/library/papers/1346340PubMed
111686740Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.Br J Pharmacol1991https://conductscience.org/library/papers/1686740PubMed
121560164The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.J Allergy Clin Immunol1992https://conductscience.org/library/papers/1560164PubMed
131357554A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.N Engl J Med1992https://conductscience.org/library/papers/1357554PubMed
142904183Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax1988https://conductscience.org/library/papers/2904183PubMed
155032708Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma.Am Rev Respir Dis1972https://conductscience.org/library/papers/5032708PubMed
164901454Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity.N Engl J Med1969https://conductscience.org/library/papers/4901454PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
37709918Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.Handb Exp Pharmacol2024https://conductscience.org/library/papers/37709918PubMed
36430683Salbutamol in the Management of Asthma: A Review.Int J Mol Sci2022https://conductscience.org/library/papers/36430683PubMed
27713285Beta-Adrenergic Agonists.Pharmaceuticals (Basel)2010https://conductscience.org/library/papers/27713285PubMed
17253458Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.Cochrane Database Syst Rev2007https://conductscience.org/library/papers/17253458PubMed
15350154A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.Drug Saf2004https://conductscience.org/library/papers/15350154PubMed
12519616Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.Cochrane Database Syst Rev2002https://conductscience.org/library/papers/12519616PubMed
10899240Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.Thorax2000https://conductscience.org/library/papers/10899240PubMed
9487346Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.Thorax1997https://conductscience.org/library/papers/9487346PubMed
9176539Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.Thorax1997https://conductscience.org/library/papers/9176539PubMed
9012556Dose-response of inhaled drugs in asthma. An update.Clin Pharmacokinet1997https://conductscience.org/library/papers/9012556PubMed
8693438Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.Thorax1996https://conductscience.org/library/papers/8693438PubMed
8611886Grand Rounds--City Hospital, Nottingham. A complicated case of community acquired pneumonia.BMJ1996https://conductscience.org/library/papers/8611886PubMed
8490515Dose equivalence of drugs for asthma.BMJ1993https://conductscience.org/library/papers/8490515PubMed
8490514Dose equivalence of drugs for asthma.BMJ1993https://conductscience.org/library/papers/8490514PubMed
8101117Bronchodilator treatment in asthma. Regular treatment with beta agonists remains unevaluated.BMJ1993https://conductscience.org/library/papers/8101117PubMed
8098239Dose equivalence of drugs for asthma.BMJ1993https://conductscience.org/library/papers/8098239PubMed
8091321Systemic effects of salbutamol and salmeterol in patients with asthma.Thorax1994https://conductscience.org/library/papers/8091321PubMed
7858856The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro.Br J Pharmacol1994https://conductscience.org/library/papers/7858856PubMed
7848546The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.Drug Saf1994https://conductscience.org/library/papers/7848546PubMed
7512898Long- versus short-acting beta 2-agonists. Implications for drug therapy.Drugs1994https://conductscience.org/library/papers/7512898PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8096416

GET https://conductscience.org/api/papers/v1/8096416/authors